New test could predict cancer return, guide treatment after liver surgery
NCT ID NCT07391007
Summary
This study aims to develop a better way to predict which patients are at high risk of their cancer returning after surgery for colorectal cancer that has spread to the liver. Researchers will combine blood tests, genetic information, and clinical factors to create a personalized risk score. This score could help doctors decide which patients might benefit most from additional chemotherapy after surgery to better control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.